ArticleFrontiers in microbiology2025
Identification of a novel hypovirulence-inducing ourmia-like mycovirus from
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Molecular characterization of a novel botourmiavirus infecting Leptosphaeria biglobosa.Archives of virology · 2026Article
- Heterologous Expression of Cryphonectria Hypovirus 1 inViruses · 2026Article
- Ginseng nonsaponins: New insights into their pharmacological potentials in inflammasome-driven inflammation and immunopathology.Journal of ginseng research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: FsoOLV1 was discovered in Results: The genome of FsoOLV1 is 2,801 nucleotides (nt) in length with a GC content of 47.05%. It encodes a 750 amino acid RNA-dependent RNA polymerase (RdRp), with a molecular weight of approximately 84.84 kDa. Phylogenetic analysis indicated that FsoOLV1 clusters within a clade containing the Discussion: This study presents the first hypovirulent ourmia-like virus, FsoOLV1, which reduces the virulence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.